-
公开(公告)号：US07360946B2
公开(公告)日：2008-04-22
申请号：US10482924
申请日：2002-07-08
Applicant: Richard Tester , Farage Al-Ghazzewi
Inventor： Richard Tester , Farage Al-Ghazzewi
CPC classification number: G01K3/04
Abstract: A thermal history indicator comprising a temperature sensitive material, a sensing device, a heat insulating material functioning to buffer the temperature sensitive material against temperature change, and an activation means. The triggering of the activation means allows a molten phase of the temperature sensitive material to interact with the sensing device, or cease interacting with the sensing device, thereby altering its chemical, biochemical or microbiological.
Abstract translation: 一种热历史指示器，包括温度敏感材料，感测装置，用于缓冲温度敏感材料以抵抗温度变化的绝热材料和激活装置。 激活装置的触发允许温度敏感材料的熔融相与感测装置相互作用，或者停止与感测装置相互作用，从而改变其化学，生物化学或微生物学。
-
2.发明申请Gastric Raft Composition Comprising Preferably Processed Starches For Inducing Satiety 审中-公开包含优选用于诱导饱腹感的加工的淀粉的胃筏组合物公开(公告)号：US20090275530A1
公开(公告)日：2009-11-05
申请号：US12225219
申请日：2006-03-16
Applicant: Richard Tester , Denise Hooper
Inventor： Richard Tester , Denise Hooper
IPC: A61K31/718 , A61K31/715 , A61P3/00 , A61P1/04
CPC classification number: A61K9/0065
Abstract: Provided are methods of inducing satiety in an individual using gastric raft compositions and compositions suitable for such methods. The gastric raft compositions may comprise processed starches such as dextrins. Also described are methods of treating diseases characterised by hypoglycaemia, such as glycogen storage disease (GSD), and diabetes.
Abstract translation: 提供了使用胃筏组合物和适合于这种方法的组合物在个体中诱导饱腹感的方法。 胃筏组合物可以包括加工的淀粉，例如糊精。 还描述了治疗以低血糖为特征的疾病如糖原贮积病（GSD）和糖尿病的方法。
-
公开(公告)号：US08507462B2
公开(公告)日：2013-08-13
申请号：US10578551
申请日：2004-11-08
Applicant: Xin Qi , Richard Tester
Inventor： Xin Qi , Richard Tester
IPC: A61K31/715
CPC classification number: A61K31/718 , A23L29/212
Abstract: Methods of controlling serum glucose levels in an individual are described, the methods including the step of administering to said individual a therapeutic food composition comprising a waxy and/or hydrothermally treated starch. The method may be used to treat or prevent hypoglycaemia in patients susceptible to hypoglycaemic episodes, for example patients with glycogen storage disease, diabetes or liver disease. The method may also be used in sports nutrition. Also described are compositions for use in the methods.
Abstract translation: 描述了控制个体中血清葡萄糖水平的方法，所述方法包括向所述个体施用包含蜡质和/或水热处理的淀粉的治疗食品组合物的步骤。 该方法可用于治疗或预防低血糖发作患者的低血糖，例如糖原贮积病，糖尿病或肝病患者。 该方法也可用于运动营养。 还描述了用于该方法的组合物。
-
公开(公告)号：US08137706B2
公开(公告)日：2012-03-20
申请号：US11596407
申请日：2005-05-16
Applicant: Farage Al-Ghazzewi , Richard Tester
Inventor： Farage Al-Ghazzewi , Richard Tester
CPC classification number: C12N9/2417 , C12N9/1048 , C12N15/1027 , C12N15/1058 , C12N15/1089
Abstract: Carbohydrates, in particular mannose containing carbohydrates, are used as a promotor of cell growth. Specifically, polysaccharide hydrolysates are shown to have superior efficacy in promoting the growth of cells, synbiotic foods, prebiotics and pharmaceutical compositions containing mannose containing carbohydrates and polysaccharide hydrolysates described.
Abstract translation: 碳水化合物，特别是含有甘露糖的碳水化合物，被用作细胞生长的启动子。 具体地说，多糖水解物被证明在促进细胞生长，合生素食物，益生元和含有含有甘露糖的碳水化合物和多糖水解物的药物组合物方面具有优异的功效。
-
公开(公告)号：US20070232617A1
公开(公告)日：2007-10-04
申请号：US11752255
申请日：2007-05-22
Applicant: Sarvajit Chakravarty , Sundeep Dugar , Qing Lu , Gregory Luedtke , Babu Mavunkel , John Perumattam , Richard Tester
Inventor： Sarvajit Chakravarty , Sundeep Dugar , Qing Lu , Gregory Luedtke , Babu Mavunkel , John Perumattam , Richard Tester
IPC: A61K31/497 , A61K31/445 , C07D401/02 , C07D403/02
CPC classification number: C07D401/06 , C07D209/18 , C07D209/42 , C07D401/14 , C07D403/06 , C07D409/12 , C07D409/14
Abstract: The invention is directed to methods to inhibit p38-α kinase using compounds comprising a phenyl or thienyl coupled through a piperidine or piperazine nucleus to an indole residue wherein the indole residue mandatorily has a substituent on the ring nitrogen which is an amino or substituted amino group.
Abstract translation: 本发明涉及使用包含通过哌啶或哌嗪核连接的苯基或噻吩基的化合物与吲哚残基一起抑制p38-α激酶的方法，其中吲哚残基在作为氨基或取代的氨基的环氮上强制取代基 。
-
Patent Agency Ranking
公开(公告)号：US07488744B2
公开(公告)日：2009-02-10
申请号：US11752255
申请日：2007-05-22
Applicant: Sarvajit Chakravarty , Sundeep Dugar , Qing Lu , Gregory R. Luedtke , Babu J. Mavunkel , John J. Perumattam , Richard Tester
Inventor： Sarvajit Chakravarty , Sundeep Dugar , Qing Lu , Gregory R. Luedtke , Babu J. Mavunkel , John J. Perumattam , Richard Tester
IPC: A01N43/64 , A61K31/41 , C07D209/04
CPC classification number: C07D401/06 , C07D209/18 , C07D209/42 , C07D401/14 , C07D403/06 , C07D409/12 , C07D409/14
Abstract: The invention is directed to methods to inhibit p38-α kinase using compounds comprising a phenyl or thienyl coupled through a piperidine or piperazine nucleus to an indole residue wherein the indole residue mandatorily has a substituent on the ring nitrogen which is an amino or substituted amino group.
Abstract translation: 本发明涉及使用包含通过哌啶或哌嗪核连接的苯基或噻吩基的化合物至吲哚残基来抑制p38-α激酶的方法，其中吲哚残基在作为氨基或取代的氨基的环氮上强制取代基 。
-
公开(公告)号：US20070077277A1
公开(公告)日：2007-04-05
申请号：US10578551
申请日：2004-11-08
Applicant: Xin Qi , Richard Tester
Inventor： Xin Qi , Richard Tester
IPC: A61F2/00
CPC classification number: A61K31/718 , A23L29/212
Abstract: Methods of controlling serum glucose levels in an individual are described, the methods including the step of administering to said individual a therapeutic food composition comprising a waxy and/or hydrothermally treated starch. The method may be used to treat or prevent hypoglycaemia in patients susceptible to hypoglycaemic episodes, for example patients with glycogen storage disease, diabetes or liver disease. The method may also be used in sports nutrition. Also described are compositions for use in the methods.
Abstract translation: 描述了控制个体中血清葡萄糖水平的方法，所述方法包括向所述个体施用包含蜡质和/或水热处理的淀粉的治疗食品组合物的步骤。 该方法可用于治疗或预防低血糖发作患者的低血糖，例如糖原贮积病，糖尿病或肝病患者。 该方法也可用于运动营养。 还描述了用于该方法的组合物。
-
公开(公告)号：US20060134006A1
公开(公告)日：2006-06-22
申请号：US10517558
申请日：2003-07-29
Applicant: Richard Tester , Xin Qi
Inventor： Richard Tester , Xin Qi
IPC: A61K31/724 , A61L9/04 , A61K9/20
CPC classification number: A61K47/36 , A61K9/0056 , A61K9/006 , A61K9/0075 , A61K9/0095 , A61K9/2059 , A61K9/7007
Abstract: A formulation, especially a pharmaceutical formulation, comprises an active agent and a carrier for the active agent, wherein the carrier comprises a beta-limit dextrin. The formulation may be a bioadhesive pharmaceutical formulation in which the beta-limit dextrin acts as a mucoadhesive agent. The active agent is a pharmaceutically active agent or a flavour or fragrance which is intended for delivery into the buccal cavity. A use of beta-limit dextrin as a disintegrant, a dispersant, and a mucoadhesive agent is also described. Also described is a nutritional product such as an energy drink which includes beta-limit dextrin as an energy source.
Abstract translation: 制剂，特别是药物制剂包含活性剂和活性剂的载体，其中载体包含β-限制糊精。 制剂可以是其中β-限制性糊精作为粘膜粘附剂的生物粘附性药物制剂。 活性剂是用于递送至颊腔的药物活性剂或风味剂或香料。 还描述了使用β-限制糊精作为崩解剂，分散剂和粘膜粘附剂。 还描述了一种营养产品，例如能量饮料，其包括β-限制糊精作为能量来源。
-
公开(公告)号：US20080226603A1
公开(公告)日：2008-09-18
申请号：US11596407
申请日：2005-05-16
Applicant: Farage Al-Ghazzewi , Richard Tester
Inventor： Farage Al-Ghazzewi , Richard Tester
CPC classification number: C12N9/2417 , C12N9/1048 , C12N15/1027 , C12N15/1058 , C12N15/1089
Abstract: Carbohydrates, in particular mannose containing carbohydrates, are used as a promotor of cell growth. Specifically, polysaccharide hydrolysates are shown to have superior efficacy in promoting the growth of cells, synbiotic foods, prebiotics and pharmaceutical compositions containing mannose containing carbohydrates and polysaccharide hydrolysates described.
Abstract translation: 碳水化合物，特别是含有甘露糖的碳水化合物，被用作细胞生长的启动子。 具体地说，多糖水解物被证明在促进细胞生长，合生素食物，益生元和含有含有甘露糖的碳水化合物和多糖水解物的药物组合物方面具有优异的功效。
-
公开(公告)号：US20060199821A1
公开(公告)日：2006-09-07
申请号：US11196650
申请日：2005-08-03
Applicant: Richard Tester , Xuefei Tan , Kurt Schinzel , Imad Nashashibi , Gregory Luedtke , Weiling Liang , Joon Jung , R. Goehring , Sundeep Dugar , Steven Do
Inventor： Richard Tester , Xuefei Tan , Kurt Schinzel , Imad Nashashibi , Gregory Luedtke , Weiling Liang , Joon Jung , R. Goehring , Sundeep Dugar , Steven Do
IPC: A61K31/5377 , A61K31/53 , A61K31/513 , A61K31/506 , C07D413/02 , C07D403/02 , C07D405/02
CPC classification number: C07D405/12 , C07D213/75 , C07D239/48 , C07D401/12 , C07D405/14 , C07D409/12 , C07D417/12
Abstract: The invention is directed to compounds and methods to inhibit p38 kinase wherein the compounds are a pyrimidine or pyridine coupled to two mandatory substituents.
Abstract translation: 本发明涉及抑制p38激酶的化合物和方法，其中化合物是与两个强制性取代基偶联的嘧啶或吡啶。
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.013 seconds)
